Advertisement
Advertisement
EW
Edwards Lifesciences Corp
82.50
USDSponsored
+0.05
+0.05%
Mar 20, 15:59 UTC -4
Closed
After-Market
82.85
+0.35
+0.42%
EW Earnings Reports
Positive Surprise Ratio
EW beat 24 of 40 last estimates.
60%
Next Report
Date of Next Report
Apr 21, 2026
Estimate for Q1 26 (Revenue/ EPS)
$1.64B
/$0.74
Implied change from Q4 25 (Revenue/ EPS)
+4.78%
/+29.82%
Implied change from Q1 25 (Revenue/ EPS)
+16.42%
/+15.63%
Edwards Lifesciences Corp earnings per share and revenue
On Feb 10, 2026, EW reported earnings of 0.57 USD per share (EPS) for Q4 25, missing the estimate of 0.63 USD, resulting in a -8.85% surprise. Revenue reached 1.57 billion, compared to an expected 1.59 billion, with a -1.45% difference. The market reacted with a +2.96% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 27 analysts forecast an EPS of 0.74 USD, with revenue projected to reach 1.64 billion USD, implying an increase of 29.82% EPS, and increase of 4.78% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Alpha Tau Medical Ltd. Ordinary Shares
Report Date
Mar 09, 2026 For Q4 25
Estimate
-$0.12
Actual
-$0.08
Surprise
+36.51%
ClearPoint Neuro, Inc. Common Stock
Report Date
Mar 17, 2026 For Q4 25
Estimate
-$0.20
Actual
-$0.27
Surprise
-32.35%
Stereotaxis, Inc. Common Stock
Report Date
Mar 09, 2026 For Q4 25
Estimate
-$0.06
Actual
-$0.06
Surprise
+10.04%
Hyperfine, Inc. Class A Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.08
Surprise
+1.96%
Rapid Micro Biosystems, Inc. Class A Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.22
Actual
-$0.28
Surprise
-23.35%
Neuronetics, Inc. Common Stock
Report Date
Mar 17, 2026 For Q4 25
Estimate
-$0.10
Actual
-$0.10
Surprise
+8.09%
InspireMD, Inc.
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.14
Surprise
+29.01%
Tenon Medical, Inc. Common Stock
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.36
Actual
-$0.22
Surprise
+40.09%
Nuwellis, Inc. Common Stock
Report Date
Mar 10, 2026 For Q4 25
Estimate
-$1.59
Actual
-$1.50
Surprise
+5.73%
FAQ
What were Edwards Lifesciences Corp's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Edwards Lifesciences Corp reported EPS of $0.57, missing estimates by -8.85%, and revenue of $1.57B, -1.45% below expectations.
How did the market react to Edwards Lifesciences Corp's Q4 2025 earnings?
The stock price moved up 2.96%, changed from $77.05 before the earnings release to $79.33 the day after.
When is Edwards Lifesciences Corp expected to report next?
The next earning report is scheduled for Apr 21, 2026.
What are the forecasts for Edwards Lifesciences Corp's next earnings report?
Based on 27
analysts, Edwards Lifesciences Corp is expected to report EPS of $0.74 and revenue of $1.64B for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement